Related Experiment Videos
Regulation of transforming growth factor-alpha mRNA expression in T3M4 human pancreatic carcinoma cells
1Department of Microbiology and Immunology, University of Arizona, Tucson.
Abstract:
Cultured human pancreatic cancer cells produce transforming growth factor-alpha (TGF-alpha), a potent mitogenic polypeptide. In the present study, we investigated the regulation of TGF-alpha mRNA expression in T3M4 human pancreatic carcinoma cells. TGF-alpha mRNA levels were quantitated by densitometric analysis of autoradiographs obtained following hybridization of size-fractionated cytoplasmic RNA with 32P-labeled cRNA coding for human TGF-alpha. There was a twofold increase in TGF-alpha mRNA levels at 2 h following addition of either epidermal growth factor (EGF) or TGF-alpha. However, TGF-alpha mRNA levels declined to near basal levels by 10 h. At 2 h, one-half maximal stimulation of TGF-alpha mRNA levels occurred at 1 nM and maximal stimulation at 4 nM of either EGF or TGF-alpha. The transcriptional inhibitor actinomycin D (Act D) and the phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), mimicked the actions of EGF and TGF-alpha. These findings indicate that the regulation of TGF-alpha mRNA expression in T3M4 cells is complex, and is mediated, in part, via the EGF receptor.
Insights
Human pancreatic cancer cells express transforming growth factor-alpha (TGF-alpha). Epidermal growth factor (EGF) and TGF-alpha treatments increase TGF-alpha mRNA levels, suggesting complex regulation partly via the EGF receptor.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Human pancreatic cancer cells, specifically T3M4 cells, produce transforming growth factor-alpha (TGF-alpha).
- TGF-alpha is a significant mitogenic polypeptide with implications in cancer progression.
Purpose of the Study:
- To investigate the regulatory mechanisms of TGF-alpha mRNA expression in T3M4 human pancreatic carcinoma cells.
- To understand the role of epidermal growth factor (EGF) and related signaling pathways in TGF-alpha regulation.
Main Methods:
- Quantification of TGF-alpha mRNA levels using Northern blot analysis and densitometry.
- Hybridization of size-fractionated cytoplasmic RNA with a 32P-labeled cRNA probe for human TGF-alpha.
- Treatment of cells with EGF, TGF-alpha, actinomycin D, and phorbol ester (TPA) to assess mRNA expression changes.
Main Results:
- Both EGF and TGF-alpha induced a twofold increase in TGF-alpha mRNA levels within 2 hours, returning to basal levels by 10 hours.
- Half-maximal stimulation of TGF-alpha mRNA occurred at 1 nM, with maximal stimulation at 4 nM for both EGF and TGF-alpha.
- Transcriptional inhibitor actinomycin D and phorbol ester TPA mimicked the effects of EGF and TGF-alpha on TGF-alpha mRNA levels.
Conclusions:
- TGF-alpha mRNA expression in T3M4 cells is complex and dynamically regulated.
- The epidermal growth factor (EGF) receptor pathway plays a significant role in mediating TGF-alpha mRNA expression.
- These findings contribute to understanding the autocrine and paracrine signaling in pancreatic cancer.